06:26 EDT Athira Pharma (ATHA) files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATHA:
- Athira Pharma downgraded to Neutral from Outperform at Mizuho
- Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
- Goldman Sachs moves Athira Pharma to Not Rated
- Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
- Athira Pharma downgraded to Market Perform from Outperform at JMP Securities